A blood test for detecting cancer early being developed by the diagnostics firm Grail failed to meet its main goal in a giant ...

The top drug regulator at the FDA told staff she plans to question the safety of taking SSRIs in pregnancy and of RSV shots ...

Was Hims' Super Bowl ad the final straw for regulators? Is the bar being lowered for psychedelic medicines? And what's happening with Moderna and FDA? Find out on "The Readout LOUD" podcast.

Rick Abrmason, formerly a chief medical officer at a subsidiary of Harrison.ai, which develops AI products to interpret ...

After years of grand ambitions, the federal government disclosed that it is months away from rolling out a centralized list ...

Federal officials have missed the legal deadline to notify the public of an upcoming ACIP meeting, raising questions about ...

Dr. Oz said your poop “should gently hit the water like Greg Louganis diving in.” In other news, the Potomac, threatened by ...

Good morning health tech readers! Please join me in congratulating my colleagues as STAT, who have been honored with a fourth Polk Award for our coverage of the Trump administration’s impacts on the ...

FDA Commissioner Marty Makary said he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring ...

NIH Director Jay Bhattacharya will add another job to his plate: acting CDC director, an administration official not authorized to speak publicly confirmed to STAT’s Chelsea Cirruzzo and Anil Oza.

Hims & Hers is buying the Australian telehealth firm Eucalyptus as it looks to make inroads in more countries globally.

Gossamer Bio will be reporting the outcome of a late-stage study in pulmonary arterial hypertension. Here's what to know.